Professional Role and Responsibilities
Kelly Richards is currently Global Biologics Product Owner - Dashboarding MVDA and Reporting at Lonza Group, headquartered in Basel, Switzerland, with association to the Greater Boston area. This role places her in charge of managing and owning dashboarding, multivariate data analysis (MVDA), and reporting systems critical to Lonza’s biologics product line, highlighting her expertise in data-driven product oversight and analytics within the pharmaceutical contract development and manufacturing organization (CDMO) sector.
She simultaneously holds key leadership and strategic roles within Lonza’s corporate data governance and culture initiatives. Specifically, Kelly leads Communications for Lonza’s local “Women Inspiring Lonza” network and serves on the Data Culture workstream of Lonza’s Global Data Governance Board, indicating her influence extends beyond operational data management to shaping organizational data strategy and culture globally.
Her responsibilities align strongly with enterprise-level data literacy advancement and global data strategy, as she is recognized as a Global Data Literacy Strategy Lead within Lonza and participates in the Global Data Strategy Council. These roles underscore her focus on enhancing data competencies and governance frameworks across Lonza’s operations.
Achievements and Industry Recognition
Kelly Richards has been publicly recognized as a “Rising Star” in Data Science by the Women Leaders in Data and AI (WLDA) tech community, specifically tagged as Data Scientist III at Lonza Biologics. This accolade reflects notable achievements in data science within biopharmaceutical manufacturing and underlines her rising professional profile in a competitive, technical environment.
She actively promotes Lonza’s hiring efforts within process data expertise, emphasizing her functional knowledge in biologics manufacturing process optimization and analytics.
Educational Background
Kelly Richards is an alumna of Syracuse University, though specific degrees or majors were not provided. This education supports her technical foundation relevant to her current advanced data and product management roles.
Geographic and Organizational Context
Kelly operates from the Greater Boston area and is also linked to Lonza’s Basel, Switzerland headquarters, positioning her at the intersection of US and European biopharma hubs. Lonza Group, as a Swiss CDMO leader, is currently undergoing strategic restructuring to enhance growth by focusing more intensively on contract manufacturing services and divesting less profitable units, targeting a 20% revenue growth and maintaining a 30% CORE EBITDA margin expected by 2025. This context is critical, as Kelly’s data and dashboarding initiatives support a company executing a growth-driven operational pivot in a highly competitive, regulated market.
Lonza Group Strategic and Market Insights Relevant to Kelly’s Role
Lonza Group is focusing on revitalizing its business by shedding lower-margin capsule operations and intensifying contract manufacturing and biologics services. The company is financially robust with optimistic growth forecasts and strategic investments into data and technology futures. Kelly’s role in global biologics product dashboarding and reporting is essential to monitoring, managing, and supporting these initiatives from a data perspective.
Additional Engagements and Insights
- Kelly Richards is active in internal corporate networks supporting diversity and inclusion, taking a leadership position in programs encouraging women’s participation and visibility in STEM and corporate roles.
- She has a visible digital presence, sharing process data expertise and advocating for career opportunities at Lonza.
- Her involvement in global data governance highlights her connection to cutting-edge data strategy initiatives fostering data literacy and governance maturity at Lonza.
This profile of Kelly Richards presents a data-centric, technically proficient professional specializing in biologics product data analytics and strategic data governance within Lonza Group’s evolving CDMO enterprise. Her leadership roles internally, combined with external recognition, position her as a key contributor to enterprise-wide data strategy and product analytics. Her work facilitates operational transparency and performance monitoring critical to Lonza’s ambitious growth and restructuring agendas in the biopharmaceutical manufacturing sector.
